Postmarketing Studies: The Work of the Drug Safety Research Unit

被引：0

作者：

David J. Finney

机构：

来源：

Drug Safety | 1999年 / 21卷

关键词：

Adis International Limited; Thalidomide; Contractual Relation; Late Professor; Prescription Event Monitoring;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：337 / 338

页数：1

共 50 条

[41] THE ROLE OF AUTOMATED RECORD LINKAGE IN THE POSTMARKETING SURVEILLANCE OF DRUG SAFETY - A CRITIQUE
SHAPIRO, S
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (04) : 371 - 386
[42] The drug safety unit in a CRO
van der Veldan, JW
DRUG SAFETY, 2004, 27 (12) : 965 - 966
[43] Early postmarketing drug safety surveillance: Data mining points to consider
Hauben, M
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1625 - 1630
[44] Does that drug work? Pitfalls in studies on the efficacy and safety of glaucoma medications
Camras, CB
Minckler, D
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (01) : 87 - 89
[45] Pharmaceutical Research and Manufacturers of America/Food and Drug Administration Cooperation in Building Capabilities for Electronic Submission of Postmarketing Safety Data
William S. Calvert
Virginia Holihan
Drug information journal : DIJ / Drug Information Association, 1999, 33 (4): : 1093 - 1099
[46] Postmarketing Safety SurveillanceIssues with Data Collection for Postmarketing Pharmacovigilance
Upasana Prabhakar
Brian Edwards
Pharmaceutical Medicine, 2010, 24 (6) : 343 - 348
[47] POSTMARKETING DRUG SURVEILLANCE
FELDMANN, EG
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
[48] Pharmaceutical Research and Manufacturers of America Food and Drug Administration cooperation in building capabilities for electronic submission of postmarketing safety data
Calvert, WS
Holihan, V
DRUG INFORMATION JOURNAL, 1999, 33 (04): : 1093 - 1099
[49] POSTMARKETING DRUG SURVEILLANCE
BORDEN, EK
GARDNER, JS
WESTLAND, MM
GARDNER, SD
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
[50] New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK
Elizabeth Lynn
Deborah Layton
Saad Shakir
Drug Safety, 2011, 34 : 89 - 91

← 1 2 3 4 5 →